Villalobos et al., 2007 - Google Patents
Current state of imaging protein-protein interactions in vivo with genetically encoded reportersVillalobos et al., 2007
- Document ID
- 5759067398620094584
- Author
- Villalobos V
- Naik S
- Piwnica-Worms D
- Publication year
- Publication venue
- Annu. Rev. Biomed. Eng.
External Links
Snippet
Signaling pathways regulating proliferation, differentiation, and inflammation are commonly mediated through protein-protein interactions as well as reversible modification (eg, phosphorylation) of proteins. To facilitate the study of regulated protein-protein interactions …
- 230000004850 protein–protein interaction 0 title abstract description 65
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Villalobos et al. | Current state of imaging protein-protein interactions in vivo with genetically encoded reporters | |
| Shekhawat et al. | Split-protein systems: beyond binary protein–protein interactions | |
| Ozawa et al. | Advances in fluorescence and bioluminescence imaging | |
| VanEngelenburg et al. | Fluorescent biosensors of protein function | |
| Paulmurugan et al. | Firefly luciferase enzyme fragment complementation for imaging in cells and living animals | |
| Greenwald et al. | Genetically encoded fluorescent biosensors illuminate the spatiotemporal regulation of signaling networks | |
| Azad et al. | Split-luciferase complementary assay: applications, recent developments, and future perspectives | |
| Wehr et al. | Split protein biosensor assays in molecular pharmacological studies | |
| Kelkar et al. | Bioluminescence based in vivo screening technologies | |
| Crivat et al. | Imaging proteins inside cells with fluorescent tags | |
| Wehr et al. | Monitoring regulated protein-protein interactions using split TEV | |
| Söderberg et al. | Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay | |
| Binkowski et al. | Engineered luciferases for molecular sensing in living cells | |
| Hamdan et al. | Monitoring protein‐protein interactions in living cells by bioluminescence resonance energy transfer (BRET) | |
| Massoud et al. | Reporter gene imaging of protein–protein interactions in living subjects | |
| González-Vera et al. | Fluorescent reporters and biosensors for probing the dynamic behavior of protein kinases | |
| Lievens et al. | Mammalian two-hybrids come of age | |
| Niu et al. | Molecular imaging with activatable reporter systems | |
| Ohmuro-Matsuyama et al. | Demonstration of protein-fragment complementation assay using purified firefly luciferase fragments | |
| Gallo | Fluorogen-activating proteins: next-generation fluorescence probes for biological research | |
| Luker et al. | Optimizing luciferase protein fragment complementation for bioluminescent imaging of protein–protein interactions in live cells and animals | |
| Xiong et al. | Engineered amber-emitting nano luciferase and its use for immunobioluminescence imaging in vivo | |
| Kim et al. | Split Gaussia luciferase-based bioluminescence template for tracing protein dynamics in living cells | |
| Lam et al. | Strategies for membrane interaction proteomics: no mass spectrometry required | |
| Wiens et al. | Surveying the landscape of optogenetic methods for detection of protein–protein interactions |